• G protein-biased LPAR1 agonism of prototypic antidepressants: Implication in the identification of novel therapeutic target for depression
  Published on 2023-09-06
  2 years ago
• Reply to Bradford: Comment on increasing ecological validity in neuropsychopharmacology research on the relationship between alcohol use and uncertain stressors
  Published on 2023-09-06
  2 years ago
• The role of neurotrophic factors in novel, rapid psychiatric treatments
  Published on 2023-09-06
  2 years ago
• Early life stress moderates the relation between systemic inflammation and neural activation to reward in adolescents both cross-sectionally and longitudinally
  Published on 2023-09-06
  2 years ago
• Rapid and novel treatments in psychiatry: the future is now
  Published on 2023-09-05
  2 years ago
• Electronic health records and stratified psychiatry: bridge to precision treatment?
  Published on 2023-09-04
  2 years ago
• Brain health in ethnically minority youth at risk for psychosis
  Published on 2023-09-04
  2 years ago

« Previous 1 … 63 64 65 66 67 … 143 Next »

• Insufficiency of ventral hippocampus to medial prefrontal cortex transmission explains antidepressant non-response
  Published on 2021-10-07
  4 years ago
• Accuracy in recognising happy facial expressions is associated with antidepressant response to a NOP receptor antagonist but not placebo treatment
  Published on 2021-10-05
  4 years ago
• Voluntary oral methamphetamine increases memory deficits and contextual sensitization during abstinence associated with decreased PKMζ and increased κOR in the hippocampus of female mice
  Published on 2021-09-30
  4 years ago
• Enhancement of the GluN2B subunit of glutamatergic NMDA receptors in rat brain areas after cocaine abstinence
  Published on 2021-09-30
  4 years ago
• Assessing the effects of methodological differences on outcomes in the use of psychedelics in the treatment of anxiety and depressive disorders: A systematic review and meta-analysis
  Published on 2021-09-14
  4 years ago
• Dopaminergic and noradrenergic modulation of stress-induced alterations in brain activation associated with goal-directed behaviour
  Published on 2021-09-14
  4 years ago
• Three regulatory compliant test systems show no signs of MDMA-related genotoxicity
  Published on 2021-09-01
  4 years ago

« Previous 1 … 63 64 65 66 67 … 124 Next »

• The time to act: early recommendations on patient care for psychiatric disorders in post-acute COVID-19 syndrome (PDPACS); Response to Llach and Ammella´s letter to the editor (Llach and Anmella 2022)
  Published on 2022-05-21
  3 years ago
• Neural underpinnings of emotion regulation subgroups in remitted patients with recently diagnosed bipolar disorder
  Published on 2022-05-11
  3 years ago
• Social Stress in Bipolar Disorder
  Published on 2022-05-11
  3 years ago
• Comparative studies of psychotropic drug use over the last seven decades: Gaps and goals in global ethnopsychopharmacology
  Published on 2022-05-11
  3 years ago
• Evaluating study designs and treatment outcomes of antidepressant pharmacogenetic clinical trials – Challenges and future perspectives. A critical review
  Published on 2022-05-11
  3 years ago
• Letter to the editor about the article “Psychiatric disorders in post-acute COVID-syndrome 3 (PDPACS): Recommendations for health care professionals” (Falconi A et al., 2022)
  Published on 2022-05-10
  3 years ago
• Cannabidiol enhancement of exposure therapy in treatment refractory patients with social anxiety disorder and panic disorder with agoraphobia: A randomised controlled trial
  Published on 2022-05-10
  3 years ago

« Previous 1 … 63 64 65 66 67 … 145 Next »